Table 3

Maspin expression in tumors of patients with and without androgen ablation therapy before prostatectomya

A.TreatmentTotal patientsMaspin expression
Positive (%)Negative (%)
With treatment2422 (91.7)2 (8.3)
Without treatment9739 (40.2)58 (59.8)
B.TreatmentTotal tumorsMaspin expression
Positive (%)Negative (%)
With treatment3629 (80.6)7 (19.4)
Without treatment19372 (37.3)121 (62.7)
  • a P < 0.001 for the unadjusted χ2 test. P < 0.001 adjusting for age race, pretreatment PSA, and pathological stage.